<DOC>
	<DOCNO>NCT01595113</DOCNO>
	<brief_summary>The purpose study evaluate safety previously conduct clinical trial cell transplant therapy use Hearticellgram-AMI patient acute myocardial infarction . This follow-up observational study target subject participate previously conduct clinical trial .</brief_summary>
	<brief_title>Safety Study Clinical Cell Transplant Therapy Using Hearticellgram-AMI Patients With Acute Myocardial Infarction</brief_title>
	<detailed_description>The safety evaluation clinical trial perform variable , occurrence severity adverse event , clinical laboratory test , vital sign , physical examination , cardiac event , cancer .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Patients elapse 2 year onset acute myocardial infarction among patient receive cell transplant therapy drug treatment least test control group previously conduct clinical trial . Subjects agree participate followup study sign consent form .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>